[TNFalpha inhibitors in the treatment of uveitis].

TNF-R1 signaling: a beautiful pathway. Science (2002) 7.98

TNF neutralization in MS: results of a randomized, placebo-controlled multicenter study. The Lenercept Multiple Sclerosis Study Group and The University of British Columbia MS/MRI Analysis Group. Neurology (1999) 4.53

Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behçet's disease with refractory uveoretinitis. J Rheumatol (2004) 3.28

Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy. Arthritis Rheum (2004) 3.06

Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol (2003) 2.67

Cytokines and autoimmunity. Nat Rev Immunol (2002) 2.51

Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res (2001) 2.06

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease. Arthritis Rheum (2001) 1.85

Induction of autoantibodies during prolonged treatment with infliximab. J Rheumatol (2003) 1.68

Development of a questionnaire for measurement of vision-related quality of life. Ophthalmic Epidemiol (1998) 1.65

Safety of tumour necrosis factor-alpha antagonists. Drug Saf (2004) 1.52

Case reports of heart failure after therapy with a tumor necrosis factor antagonist. Ann Intern Med (2003) 1.51

Quantitative assessment of the integrity of the blood-retinal barrier in mice. Invest Ophthalmol Vis Sci (2002) 1.20

Efficacy of etanercept in preventing relapse of uveitis controlled by methotrexate. Arch Ophthalmol (2003) 1.16

Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis. J Autoimmun (1998) 1.15

Anti-tumor necrosis factor-alpha therapy with infliximab as an alternative to corticosteroids in the treatment of human leukocyte antigen B27-associated acute anterior uveitis. Ophthalmology (2002) 1.15

Infliximab for recurrent, sight-threatening ocular inflammation in Adamantiades-Behçet disease. Ann Intern Med (2004) 1.13

Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? Arthritis Rheum (2003) 1.05

Regulation of ocular inflammation--what experimental and human studies have taught us. Prog Retin Eye Res (2001) 1.04

Does etanercept induce uveitis? Br J Ophthalmol (2003) 0.97

Neutralizing tumor necrosis factor activity leads to remission in patients with refractory noninfectious posterior uveitis. Arch Ophthalmol (2004) 0.95

Mice deficient in tumor necrosis factor receptors p55 and p75, interleukin-4, or inducible nitric oxide synthase are susceptible to endotoxin-induced uveitis. Invest Ophthalmol Vis Sci (1998) 0.95

Does safety make a difference in selecting the right TNF antagonist? Arthritis Res Ther (2004) 0.89

Long-term outcome of etanercept therapy in children with treatment-refractory uveitis. Arthritis Rheum (2003) 0.85

Recurrent uveitis in a patient with juvenile spondyloarthropathy associated with tumour necrosis factor alpha inhibitors. Ann Rheum Dis (2003) 0.82